英文名称:SU-DHL-4
货号:GCL-0692
价格: ¥1800.00 ¥1800.00
产品详情
产品信息
物种 | Human |
生长特性 | 悬浮细胞 |
细胞形态 | 淋巴母细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[GPM150110]+10% FBS[163210]+1% P/S[GPB180120] 培养条件: 温度:37℃ |
推荐传代比例 | 5×10⁵-1×10⁶ cells/mL |
推荐换液频率 | 2-3次/周 |
注意事项 |
|
参考资料(来源文献)
背景描述 | Established from the peritoneal effusion of a 38-year-old man with B-NHL (diffuse large cell, cleaved cell type; originally described as "diffuse histiocytic lymphoma") in 1975; cell line carries EZH2 Y641S mutation; assigned to GCB-like lymphoma subtype (germinal center B-cell). Exome and RNA sequence data are available (see Ref 18187 and Exome sequence and RNA-Seq). |
年龄(性别) | 38Y |
组织来源 | 腹腔积液 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 淋巴瘤细胞 |
基因表达情况 | IgG+; Kappa+; IgM-; IgA-; IgD-; Lambda-; This cell line has relatively high expression levels of Bax; Bak; AIF; high caspase-9 activity. |
保藏机构 | ATCC; CRL-2957 DSMZ; ACC-495 |
相关文献
-
期刊:ANALYTICAL CHEMISTRY
DOI:10.1021/acs.analchem.4c06244
影响因子:6.7
-
期刊:PLoS One
DOI:10.1371/journal.pone.0323965
影响因子:2.9
相关产品: SU-DHL-4 Cells Line
-
期刊:BIOCHEMICAL GENETICS
DOI:10.1007/s10528-025-11100-8
影响因子:2.1
-
期刊:FREE RADICAL BIOLOGY AND MEDICINE
DOI:10.1016/j.freeradbiomed.2024.06.014
影响因子:7.1
相关产品: LDH Activity Assay Kit, GSH Colorimetric Assay Kit, GST Activity Assay Kit, ALT/GPT Activity Assay Kit, AST/GOT Activity Assay Kit, HT-1080 [HT1080] Cells Line, HuH-7 Cells Line, Caov-3 Cells Line, SU-DHL-4 Cells Line, BxPC-3 Cells Line, NB4 Cells Line, Jurkat, Clone E6-1 Cells Line, U-937 Cells Line
-
期刊:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI:10.1007/s00432-024-05615-7
影响因子:3.6
相关产品: DB Cells Line, SU-DHL-4 Cells Line, RPMI-1640, BCA Protein Colorimetric Assay Kit
-
期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI:10.1016/j.taap.2024.117148
影响因子:3.3
相关产品: Cell Ferrous Iron Colorimetric Assay Kit, OCI-Ly3 Cells Line, SU-DHL-4 Cells Line, HMy2.CIR] Cells Line, WSU-DLCL2 Cells Line, U-2932 Cells Line
-
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment(2023)
期刊:CANCER IMMUNOLOGY IMMUNOTHERAPY
DOI:10.1007/s00262-023-03526-z
影响因子:5.8
相关产品: SU-DHL-4 Cells Line, DB Cells Line